ContraFect Corp. (NASDAQ:CFRX) – Investment analysts at William Blair issued their Q3 2016 EPS estimates for shares of ContraFect Corp. in a research note issued on Tuesday. William Blair analyst Y. Xu anticipates that the firm will post earnings per share of ($0.18) for the quarter. William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for ContraFect Corp.’s Q4 2016 earnings at ($0.18) EPS, FY2016 earnings at ($0.98) EPS, FY2017 earnings at ($0.68) EPS and FY2018 earnings at ($0.75) EPS.
ContraFect Corp. (NASDAQ:CFRX) last released its quarterly earnings results on Tuesday, August 9th. The company reported ($0.35) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.27) by $0.08.
CFRX has been the subject of several other research reports. Maxim Group downgraded ContraFect Corp. from a “buy” rating to a “hold” rating in a research note on Friday, July 22nd. Piper Jaffray Cos. started coverage on ContraFect Corp. in a research note on Thursday, July 28th. They issued an “overweight” rating for the company.
ContraFect Corp. (NASDAQ:CFRX) remained flat at $2.43 during mid-day trading on Friday. The stock had a trading volume of 7,817 shares. ContraFect Corp. has a 52-week low of $2.10 and a 52-week high of $5.35. The stock’s market cap is $100.94 million. The stock has a 50 day moving average price of $2.38 and a 200 day moving average price of $2.88.
Several hedge funds have recently added to or reduced their stakes in the stock. Cormorant Asset Management LLC boosted its stake in ContraFect Corp. by 256.0% in the first quarter. Cormorant Asset Management LLC now owns 834,406 shares of the company’s stock valued at $2,837,000 after buying an additional 600,000 shares during the last quarter. Adage Capital Partners GP L.L.C. boosted its stake in ContraFect Corp. by 50.0% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,500,000 shares of the company’s stock valued at $5,100,000 after buying an additional 500,000 shares during the last quarter. Sunbelt Securities Inc. acquired a new stake in ContraFect Corp. during the second quarter valued at $578,000. Finally, BlackRock Fund Advisors boosted its stake in ContraFect Corp. by 41.9% in the second quarter. BlackRock Fund Advisors now owns 57,923 shares of the company’s stock valued at $167,000 after buying an additional 17,092 shares during the last quarter. 13.55% of the stock is currently owned by hedge funds and other institutional investors.
In related news, CEO Steven C. Gilman bought 20,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The stock was acquired at an average price of $2.48 per share, for a total transaction of $49,600.00. Following the purchase, the chief executive officer now directly owns 20,000 shares in the company, valued at $49,600. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 15.00% of the stock is owned by company insiders.
Receive News & Ratings for ContraFect Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corp. and related companies with MarketBeat.com's FREE daily email newsletter.